Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Forumberichten
Door:
flosz
Forum:
uniQure
Since last November, we’ve been waiting for more data from uniQure about the ongoing trial of AMT-130, expected in June. This release involves two years of data from the first, low-dose cohort of ten, and one year of ...
Door:
flosz
Forum:
uniQure
At FDA meeting, gene therapy experts wrestle with fields blindspots www.biopharmadive.com/news/fda-gene-t...
Door:
flosz
Forum:
Galapagos
quote:voda schreef op 25 maart 2021 14:15:Nederlandse start-up haalt 40 miljoen op voor corona-neusspraysGepubliceerd op 25 maart 2021 13:00 | Views: 1.761AMSTERDAM (ANP) - De Nederlandse biotechstart-up Leyden Labs o...
Door:
flosz
Forum:
uniQure
Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease Pathology res.mdpi.com/d_attachment/brainsci/br....
Door:
flosz
Forum:
uniQure
Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery. www.nature.com/articles/s41434-020-01...
Door:
flosz
Forum:
Koffiekamer
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques www.nature.com/articles/s41586-020-26...Ad26 PER.C6 $JNJ ($CRXL )Janssenwww.prnewswire.com/news-releases/sing...
Door:
flosz
Forum:
uniQure
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques www.nature.com/articles/s41586-020-26...Ad26 PER.C6 $JNJ ($CRXL )Janssen ????????www.prnewswire.com/news-releases/sing...
Door:
flosz
Forum:
uniQure
GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop content.iospress.com/articles/journal...AAV2-GDNF for Advanced #ParkinsonsDisease www.clinicaltrials.gov/ct2/show/NCT01... (AAV2-GDNF= ex-QURE)
Door:
flosz
Forum:
uniQure
PF-06838435 (SPK-9001, $ONCE) Hemophilia BMean Activity 22.9 (9.89)Peak Activity29.1 (11.63)twitter.com/_b_i_o_t_e_c_h_/status/12...
Door:
flosz
Forum:
uniQure
Hemophilia A Gene Therapy, AMT-180, Continues to Show Activity, Safety in Animals ..................AMT-180 is a gene therapy being developed by uniQure to treat hemophilia A patients, including those with FVIII inhib...
Door:
flosz
Forum:
Koffiekamer
Hoe Nederland de kennis voor een kansrijk coronavaccin uit handen gaf.Brus: “Als het aan ons had gelegen, was Nederland bij een pandemie verzekerd geweest van voldoende vaccins, maar de overheid had nul belangstelling...
Door:
flosz
Forum:
uniQure
twitter.com/_b_i_o_t_e_c_h_/status/12...
Door:
flosz
Forum:
Galapagos
quote:dewarry schreef op 7 januari 2020 11:54:twitter.com/floszcrxl/status/12145000...Dat is snel...haha
Door:
flosz
Forum:
uniQure
Update (Jan.2019) on Phase I/II Clinical Trial of Intracerebral Administration of rAAV2/5hNAGLU Vector in Children with MPSIIIB www.youtube.com/watch?v=3aaKv_gcab4twitter.com/floszcrxl/status/12007288...
Door:
flosz
Forum:
uniQure
quote:Tex Mex schreef op 3 september 2019 10:17:“Slybera”, haha.www.statnews.com/2019/09/01/biohacker...Zal wel overwaaien...Das Kopieren und Verkaufen des Arzneimittels knnte jedoch das geistige Eigentum von UniQure ...
Door:
flosz
Forum:
uniQure
Thx. Prof.!Collaboration and License Agreements with uniQure biopharma B.V.In August 2019, we entered into an Amended and Restated Collaboration and License Agreement (the Amended and Restated uniQure Agreement) with ...
Door:
flosz
Forum:
Galapagos
$MOR Announces Intention to Submit Marketing Authorization Application for Tafasitamab to EMA. $MOR Discloses Biomarker to Stratify Patient Population in B-MIND Study of Tafasitamab plus Bendamustine in r/r DLBCL. Q2 ...
Door:
flosz
Forum:
Galapagos
Gogogoooooo met die opbrengst...twitter.com/floszcrxl/status/11446148...
Door:
flosz
Forum:
Koffiekamer
quote:rationeel schreef op 16 juni 2019 14:00:Nu even afwachten wat er verder gebeurt. www.bloomberg.com/amp/news/articles/2...twitter.com/floszcrxl/status/11391217...
Door:
flosz
Forum:
Galapagos
Gene-Therapy Firm UniQure Explores Options Including SaleUniQure NV is exploring options including a potential sale amid interest from pharmaceutical companies looking to expand in gene therapy, people with knowledge ...
Door:
flosz
Forum:
Galapagos
quote:Lama Daila schreef op 8 juni 2019 10:21:Gestart op het Light-draadje, maar het zal (hoogstwaarschijnlijk) hier op het Toledo-draadje ook op zijn plaats.Galapagos heeft een nieuw patent gepubliceerd dat vermoedel...
Door:
flosz
Forum:
uniQure
quote:Vitavita schreef op 31 mei 2019 00:27:May 30, 2019 04:05 PMKortom, de huidige relationship is onduidelijk.Zie www.iex.nl/Forum/Topic/1309036/1/nieu...
Door:
flosz
Forum:
uniQure
Bristol-Myers Squibb CollaborationIn 2015, we entered into an agreement with BMS that provides exclusive access to our gene therapy technology platform for multiple targets primarily focused on cardiovascular diseases...
Door:
flosz
Forum:
uniQure
$QURE #AAN2019 Development of an AAV-based microRNA Gene Therapy for Treating Spinocerebellar Ataxia Type 3 SCA3uniqure.com/2019-AAN-SCA3Poster.pdftools.eurolandir.com/tools/Pressrelea...
Door:
flosz
Forum:
uniQure
$QURE #ASGCT19 APRIL29-MAY2,WASHINGTON,D.C. Therapeutic Rescue of Spinal Muscular Atrophy Mouse Models with AAV9-Exon Specific U1 snRNASpinal Muscular Atrophy results from loss-of-function mutations in SMN1 but corr...
Forumactiviteit
Aantal posts
7.005
Gegeven aanbevelingen
2.795 Ontvangen aanbevelingen
5.298
Aanbevelingen/Posts
0,76